Is it healthy to strive for the status of being a “perfect parent”? New research shows the answer is no.
Advertisement
AI technology to detect elevated CKD risk in people with diabetes received Breakthrough Device designation from the FDA.
Value-based kidney care provider Evergreen Nephrology has added two new executives to its leadership team.
Researchers conducted a comprehensive analysis to determine the association between HCC disease stage and prognosis.
The gene therapy, which costs $3.1 million, was approved by the FDA in December 2023.
How does sodium bicarbonate affect bone health markers in patients with chronic kidney disease (CKD)?
RNA biomarkers are not reliant on age-related methylation patterns that may result in test performance variability.
The effects of primary tumor and LN volume on clinical outcomes in ESCC following neoadjuvant CCRT and surgery are unknown.
Chadi is joined by Stephanie Chuang, a patient advocate, cancer survivor, and founder of The Patient Story website.
DocWire Content Partners
Gain insights from The CardioNerds, a group of cardiology experts who aim to democratize cardiovascular education.
Fundamentals, core concepts, and important management approaches in the field of hematology and oncology
Dr. Chadi Nabhan, a renowned voice in hematology and oncology, tackles a multitude of relevant health care topics.
Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.
Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.
Review important issues in the rheumatology space, including lupus, rheumatoid arthritis, and more, from Dr. Maheswaranathan.
Powered by DocWire News
The Latest From GI Oncology Now
Researchers conducted a comprehensive analysis to determine the association between HCC disease stage and prognosis.
RNA biomarkers are not reliant on age-related methylation patterns that may result in test performance variability.
The effects of primary tumor and LN volume on clinical outcomes in ESCC following neoadjuvant CCRT and surgery are unknown.
PRECEDE offers testing for individuals at high risk of pancreatic cancer, with multiple testing sites located globally.
Dr. Rodón Ahnert compares the differences of sacituzumab tirumotecan use in the second- vs third-line setting for patients.
Dr. Goel discusses how his team's liquid biopsy can be used with CA19-9 to boost the accuracy of detecting pancreatic cancer.
The Latest From Heme Today
The gene therapy, which costs $3.1 million, was approved by the FDA in December 2023.
Phase III data from the CLIMB SCD-121 trial verified the efficacy of exa-cel in eliminating vaso-occlusive crises in SCD.
Age, weight, graft failure, and donor type are some predictors of pain crisis after HSCT in patients with SCD.
The US FDA has approved fidanacogene elaparvovec-dzkt, a gene therapy for adults with hemophilia B.
Oral and intravenous iron supplementation effectively treated restless legs syndrome in patients with iron deficiency anemia.
In the one-year, fixed-dose extension period of the ESTIMATE study, mitapivat showed continued safety and efficacy in SCD.
